BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
MYC
,
G-protein-coupled receptor binding
,
Breast Cancer
,
Prostate
,
Cisplatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PNPs
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
L1000 CMAP - Adipose MSC ASC52telo cells with shRNA-mediated gene knockdown
L1000 CMAP Liver cancer HEP G2 cells with gene overexpression perturbations
L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for PNPs
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
BlueWind Reprieve System for the Treatment of PNP
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Adult Healthy Participants
A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Doce…
BlueWind Medical Reprieve System for the Treatment of PNP
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ